Allen & Overy has advised Husky Injection Molding Systems on its acquisition of Schöttli Group. The sale is expected to close in early December. Financial details have not been disclosed.
Husky Injection Molding Systems is a supplier of injection-moulding equipment and services to the plastics industry. Schöttli Group specialises in medical and closure mould making with leadership in a number of medical applications, such as syringes, infusion/transfusion products, diagnostic systems and feminine care items. The acquisition will allow Husky to strengthen its understanding in these specific areas.
The Allen & Overy team was led by partner Dr Hans Schoneweg together with senior associate Dr Rüdiger Klüber (both corporate/M&A, Hamburg).
Further team members comprised partners Dr Ellen Braun (antitrust, Hamburg), Dr Jens Matthes (intellectual property or IP, Dusseldorf), Kenneth Rivlin (compliance and environmental, New York), Eric Shube (corporate/M&A, New York), Richard Kim (corporate/M&A, Shanghai), senior counsel David Ernst (antitrust) and Brian Jebb (corporate, both New York), counsel Marie-Luise von Buchwaldt (corporate, Hamburg) and Peter Myners (corporate/M&A, Luxembourg), senior associates Daniel Martin Schulz (corporate/M&A, Hamburg), Dr René Galle (antitrust, Hamburg), Dr Philipp Cepl (IP, Dusseldorf), associates Juliane Schmidt (corporate/M&A), David Hössl (commercial), Sören Seidel (employment), Vera Thiemann, Dr Daisy Walzel, (both antitrust, all Hamburg), Monica Arduini (corporate/M&A), Julianne Susman (compliance and environmental, both New York), Chris Zhu, Audrey Zhi, Simon Shi (all corporate/M&A, Shanghai), Miray Kavruk (IP, Dusseldorf) and Louise Rabeux (corporate/M&A, London).
Further advice in relation to local Swiss law was provided by Markus Vischer and Lucas Hänni, both Walder Wyss. In house, Husky was advised by Michael McKendry (vice-president, corporate services and general counsel) and Chris Vollmershausen (legal counsel).